# K014053: Conduit TCP Granules

- Pathway: 510(k) (Traditional)
- Applicant: Depuyacromed
- Decided: Mar 8, 2002 after 88 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K990131 (1999). 2 ancestors in all.
7 later devices descend from it; 3 cite it directly.
0 of 10 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K994337: Vitoss Scaffold Synthetic Cancellous Bone Void Filler, Orthovita Co. (2000) Summary page 1.
- K990131: Pro Osteon Implant 500R Resorbable Bone Graft Substitute, Interpore Cross Intl. (1999) Summary page 1.

## Most influential descendants
- K030178: Calcigen Psi Bone Graft Substitute (2003), 3 descendants of its own
- K050357: Camceram TCP (2005), 1 descendant of its own
- K032286: Calcigen Psi Bone Graft Substitute (2003), 1 descendant of its own
- K102937: Osteophil Beta-TCP (2010), 0 descendants of its own
- K063346: Pro Osteon 500R (2007), 0 descendants of its own

## Indications for use
The Conduit™ TCP Granules are indicated for filling bone voids or defects of the skeletal system (such as the extremities, spine, and the pelvis) that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Conduit™ TCP Granules is a bone graft substitute that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K014053
Methodology: https://510kreport.com/methodology